Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT00903968 |
| Title | Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Dana-Farber Cancer Institute |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | United States | Details | |
| Cape Cod Hospital | Hyannis | Massachusetts | 02601 | United States | Details | |
| Milford Hospital | Milford | Massachusetts | 01757 | United States | Details | |
| Newton-Wellesley Hospital | Newton | Massachusetts | 02462 | United States | Details | |
| Cancer Treatment Centers of America (Eastern Regional Medical Center) | Philadelphia | Pennsylvania | 19124 | United States | Details |